Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.

Bachmann CJ, Manthey T, Kamp-Becker I, Glaeske G, Hoffmann F.

Res Dev Disabil. 2013 Sep;34(9):2551-63. doi: 10.1016/j.ridd.2013.05.028. Epub 2013 Jun 7.

PMID:
23747941
2.

Authors' response to Bachmann and Hoffman's comments on psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study.

Wong IC, Hsia Y.

Psychopharmacology (Berl). 2015 Mar;232(5):985-8. doi: 10.1007/s00213-014-3859-9. Epub 2015 Jan 29. No abstract available.

PMID:
25627463
3.

Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany.

Bachmann CJ, Roessner V, Glaeske G, Hoffmann F.

Eur Child Adolesc Psychiatry. 2015 Feb;24(2):199-207. doi: 10.1007/s00787-014-0563-6. Epub 2014 Jun 3.

PMID:
24888751
4.

Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study.

Hsia Y, Wong AY, Murphy DG, Simonoff E, Buitelaar JK, Wong IC.

Psychopharmacology (Berl). 2014 Mar;231(6):999-1009. doi: 10.1007/s00213-013-3263-x. Epub 2013 Sep 5.

PMID:
24005531
5.

Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.

Murray ML, Hsia Y, Glaser K, Simonoff E, Murphy DG, Asherson PJ, Eklund H, Wong IC.

Psychopharmacology (Berl). 2014 Mar;231(6):1011-21. doi: 10.1007/s00213-013-3140-7. Epub 2013 May 17.

7.

Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

Bachmann CJ, Lempp T, Glaeske G, Hoffmann F.

Dtsch Arztebl Int. 2014 Jan 17;111(3):25-34. doi: 10.3238/arztebl.2014.0025.

8.

Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.

Madden JM, Lakoma MD, Lynch FL, Rusinak D, Owen-Smith AA, Coleman KJ, Quinn VP, Yau VM, Qian YX, Croen LA.

J Autism Dev Disord. 2017 Jan;47(1):144-154. doi: 10.1007/s10803-016-2946-7.

9.

Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.

Adler BA, Wink LK, Early M, Shaffer R, Minshawi N, McDougle CJ, Erickson CA.

Autism. 2015 Jan;19(1):102-6. doi: 10.1177/1362361314524641. Epub 2014 Feb 26.

PMID:
24571823
10.

Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.

Schubart JR, Camacho F, Leslie D.

Autism. 2014 Aug;18(6):631-7. doi: 10.1177/1362361313497537. Epub 2013 Oct 28.

PMID:
24165274
11.

[Hyperkinetic disorders in childhood and adolescence- an analysis of KinderAGATE 2009-2012].

Stegmann B, Rexroth CA, Wenzel-Seifert K, Haen E.

Z Kinder Jugendpsychiatr Psychother. 2015 Mar;43(2):101-14. German.

PMID:
25951625
12.

Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

Rosenberg RE, Mandell DS, Farmer JE, Law JK, Marvin AR, Law PA.

J Autism Dev Disord. 2010 Mar;40(3):342-51. doi: 10.1007/s10803-009-0878-1.

PMID:
19806445
13.

A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.

Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG.

J Autism Dev Disord. 2009 Sep;39(9):1339-49. doi: 10.1007/s10803-009-0750-3. Epub 2009 May 12.

15.

Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators; Centers for Disease Control and Prevention.

MMWR Surveill Summ. 2007 Feb 9;56(1):12-28.

16.

Aripiprazole for autism spectrum disorders (ASD).

Hirsch LE, Pringsheim T.

Cochrane Database Syst Rev. 2016 Jun 26;(6):CD009043. doi: 10.1002/14651858.CD009043.pub3. Review.

PMID:
27344135
17.

An update on pharmacotherapy for autism spectrum disorder in children and adolescents.

Ji N, Findling RL.

Curr Opin Psychiatry. 2015 Mar;28(2):91-101. doi: 10.1097/YCO.0000000000000132. Review.

PMID:
25602248
18.

New directions in the treatment of autism spectrum disorders from animal model research.

Chadman KK, Guariglia SR, Yoo JH.

Expert Opin Drug Discov. 2012 May;7(5):407-16. doi: 10.1517/17460441.2012.678828. Epub 2012 Apr 12. Review.

PMID:
22494457
19.

Prescription trends in children with pervasive developmental disorders: a claims data-based study in Japan.

Satoh M, Obara T, Nishigori H, Ooba N, Morikawa Y, Ishikuro M, Metoki H, Kikuya M, Mano N.

World J Pediatr. 2016 Nov;12(4):443-449. Epub 2016 Jun 10.

PMID:
27286689
20.

Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2009 Dec 18;58(10):1-20. Erratum in: MMWR Surveill Summ. 2010 Aug 6;59(30):956.

Supplemental Content

Support Center